ANTIFUNGAL ACTIVITY OF REUTERIN AGAINST AFLATOXIGENIC ASPERGILLUS FLAVUS
DOI:
https://doi.org/10.55251/jmbfs.10032Keywords:
aflatoxigenic, aflatoxin B1, antifungal, Aspergillus flavus, reuterinAbstract
Reuterin is a secondary metabolite of the lactic acid bacteria Limosilactobacillus reuteri having broad antimicrobial activity. This study aimed to determine the antifungal activity of reuterin against aflatoxigenic Aspergillus flavus (A. flavus). The aflatoxigenic A. flavus BIO 33212 isolated from Indonesian nutmeg was used in this study. The minimum inhibitory concentration (MIC) of reuterin based on radial growth and colony-forming assays in solid and liquid fat-enriched media against A. flavus was determined. The effect of reuterin on the morphological structure of A. flavus was investigated by scanning electron microscopy (SEM). The aflatoxin B1 (AFB1) produced by A. flavus was evaluated by enzyme-linked immunosorbent assay. Reuterin effectively prolonged the lag phase and decreased the growth rate of A. flavus. At 2 and 4 mM, reuterin demonstrated radial growth inhibition by 5.59% and 35.40%, respectively, while the reductions in colony numbers were 18.36% and 69.51%, respectively. At higher concentrations (6 and 8 mM), the fungal growth was inhibited and reduced completely (100%). SEM revealed the disruption of hyphae and conidiophore development and conidial damage. However, a contradictory phenomenon was found when reuterin at < 6 mM triggered a higher production of AFB1.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Widiati Purnawita, Winiati Pudji Rahayu, Hanifah Nuryani Lioe, Siti Nurjanah, Romsyah Maryam
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers published in the Journal of Microbiology, Biotechnology and Food Sciences are published under a CC-BY licence (CC-BY 4.0). Published materials can be shared (copy and redistribute the material in any medium or format) and adapted (remix, transform, and build upon the material for any purpose, even commercially) with specifying the author(s).